Top 5 Stocks New Mets Owner Steve Cohen Was Buying in Q3
Below we’ll check out the Top 5 Stocks New Mets Owner Steve Cohen Was Buying in Q3.
Posts Tagged ‘Eli Lilly & Co (LLY)’
10 Biggest Antidepressant Drug Companies In 2017
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
10 Least Obese Countries in the World
The 10 least obese countries in the world are mostly from Asia and Africa.
The 10 Largest Pharmaceutical Companies In the World
Wondering which are the largest pharmaceutical companies in the world? The collective biotech and pharmaceutical industry is known to be one of the most active and wealthy industries...
Exosome-Eli Lilly Deal: The Details You Need To Know
Exosome-Eli Lilly deal: Yesterday, Exosome Diagnostics announced it has entered into a collaboration agreement with Eli Lilly & Co. (NYSE:LLY).
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Hedge Funds Are Buying Bristol Myers Squibb Co. (BMY)
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): Dreamboat Data? Not Exactly.
MannKind Corporation (NASDAQ:MNKD) ended up more than 10% on Wednesday, after the biotech announced positive results for two phase 3 trials testing its inhaled insulin Afrezza...
MannKind Corporation (MNKD): What’s the Latest: New Insulin Inhaler, Rating Reiterated by Zacks, Matthew J. Pfeffer & More
The long promise of insulin that diabetics can inhale appears to be moving closer to the market.
Eli Lilly & Co. (LLY): Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
The battle against cancer is both valiant and frustrating.
A Smart Eli Lilly & Co. (LLY) Investor Does What Now?
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Should You Buy AstraZeneca plc (ADR) (AZN)?
Is AstraZeneca plc (ADR) (NYSE:AZN) a healthy stock for your portfolio? Investors who are in the know are getting more bullish.
AbbVie Inc (ABBV): Hedge Funds and Insiders Are Bullish, What Should You Do?
According to most market participants, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear.
This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Co. (NYSE:BMY) was in 33 hedge funds' portfolio at the end of the first quarter of 2013.
Bristol Myers Squibb Co. (NBMY), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part I
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
$28 Billion Hedge Fund Winton Capital’s Top Stock Picks for 2013: Consolidated Edison, Inc. (ED), Verizon Communications Inc. (VZ), Eli Lilly & Co. (LLY)
Winton Capital was founded by David Harding in 1997. Primarily a quantitative fund, it had over $25 billion in assets under management roughly a year ago.
Which Pharmaceutical Stock Should You Invest In? – Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
A common trap many investors fall into is becoming overly confident in their views. This leads to wagering too much on a single outcome.
Newest Plays for Billion-Dollar Bridger Management
Most hedge fund managers can only dream of breaking the “billion-dollar ceiling” of the big leagues, and they remain content with a critical mass of nine-figures or less.
Buyers of Titanium Metals Corp. calls ahead of PCP deal raking it in as shares soar
Titanium Metals Corp (NYSE:TIE) – Shares in the producer of titanium melted and mill products are up better than 40% on Monday after Precision Castparts Corp.
Holding Steady: AUER’s Growth Strategy Not for the Weak
Every once in a while we come across an investing strategy that gives a moment of pause.
3 High-Yield Pharma Stocks With Major Catalysts
Income investors can find attractive high-yields in the pharmaceutical sector right now. Many major drug makers, including familiar names like Merck & Co., Inc.
These Stocks Are D.E. Shaw’s Top Dividend Plays
D.E. Shaw & Co., LP, founded by D.E. Shaw in 1988, is a New York-based investment management firm managing over $26 billion in investment capital.
10 Best Stocks For 2012 By Merrill Lynch
Earlier this month Bank of America/Merrill Lynch (BAC) strategist Savita Subramanian prepared a list of Merrill Lynch’s 10 favorite stocks for 2012.
